Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ADCC”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Early research (Phase 1)Study completedNCT03663998
What this trial is testing

Optimising DNA Vaccinations in Healthy Volunteers

Who this might be right for
HIV-1-infection
Imperial College London 36
Testing effectiveness (Phase 2)Looking for participantsNCT03874026
What this trial is testing

Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients

Who this might be right for
Colorectal CancerADCC
National Cancer Institute, Naples 34
Early research (Phase 1)Study completedNCT03905135
What this trial is testing

Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies

Who this might be right for
Peripheral T-cell Lymphoma NOSMycosis FungoidesSezary Syndrome+1 more
National Cancer Institute (NCI) 8
Early research (Phase 1)Study completedNCT04634435
What this trial is testing

Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Biohaven Pharmaceuticals, Inc. 7
Early research (Phase 1)Study completedNCT00079716
What this trial is testing

Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma

Who this might be right for
Multiple Myeloma
Seagen Inc. 44
Not applicableNot Yet RecruitingNCT07641699
What this trial is testing

Registry-Based Study Across the Spectrum of Degenerative Cervical Myelopathy

Who this might be right for
Degenerative Cervical MyelopathyNon-myelopathic Degenerative Cervical Cord CompressionAsymptomatic Degenerative Cervical Cord Compression+1 more
Wangjing Hospital, China Academy of Chinese Medical Sciences 200
Early research (Phase 1)Study completedNCT04185220
What this trial is testing

Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome

Who this might be right for
Adult T-Cell Lymphoma/LeukemiaSezary SyndromeMycosis Fungoides
National Cancer Institute (NCI) 6
Early research (Phase 1)Study completedNCT01254617
What this trial is testing

Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer

Who this might be right for
Recurrent Colon CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+39 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Looking for participantsNCT06991114
What this trial is testing

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Who this might be right for
Refractory Rheumatoid Arthritis (RA)Idiopathic Inflammatory Myopathies (IIMs)Systemic Sclerosis (SSc)+6 more
Artiva Biotherapeutics, Inc. 90
Early research (Phase 1)UnknownNCT03554889
What this trial is testing

Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells

Who this might be right for
Advanced CancerADCCNK Cell Mediated Immunity+2 more
Hangzhou Cancer Hospital 21
Early research (Phase 1)Ended earlyNCT03759184
What this trial is testing

Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia

Who this might be right for
LeukemiaLymphocyticChronic+1 more
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Study completedNCT03693300
What this trial is testing

Determine Safety of Durvalumab After Sequential Chemo Radiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
AstraZeneca 117
Testing effectiveness (Phase 2)Ended earlyNCT04150562
What this trial is testing

Avelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal Carcinoma

Who this might be right for
Clear-Cell Renal Carcinoma
National Cancer Institute (NCI) 2
Testing effectiveness (Phase 2)Ended earlyNCT05099549
What this trial is testing

Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers

Who this might be right for
Squamous Cell Carcinoma of Head and NeckCarcinoma, Non-Small-Cell LungColorectal Neoplasms+3 more
NKGen Biotech, Inc. 11
Large-scale testing (Phase 3)Ended earlyNCT00169104
What this trial is testing

Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function

Who this might be right for
Metastatic Breast Cancer
Dartmouth-Hitchcock Medical Center 23
Early research (Phase 1)Ended earlyNCT05930951
What this trial is testing

Study of OBT076 Associated or Not in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck

Who this might be right for
Adenoid Cystic Carcinoma of the Head and Neck
Groupe Oncologie Radiotherapie Tete et Cou 19
Testing effectiveness (Phase 2)WithdrawnNCT04985825
What this trial is testing

Imgatuzumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Carcinoma
Pega-One S.A.S.
Large-scale testing (Phase 3)Study completedNCT03217422
What this trial is testing

ADCC Mediated B-Cell dEpletion and BAFF-R Blockade

Who this might be right for
Autoimmune Hepatitis
Novartis Pharmaceuticals 68
Early research (Phase 1)Looking for participantsNCT06630806
What this trial is testing

Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma

Who this might be right for
Plasma Cell Myeloma Refractory
Sanofi 87
Early research (Phase 1)WithdrawnNCT05700630
What this trial is testing

Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia

Who this might be right for
HIV-1-infectionARTCd4+ Lymphocyte Deficiency+2 more
Masonic Cancer Center, University of Minnesota
Next Page